Transgenic mouse, risk, depression, and cognitive impairment were the most powerful keywords that have emerged in recent years.<h4>Conclusion</h4>Research on IGF-1 and AD has continued to grow. This evidence concerns the gene IGF1 and depressive symptom measurement.